Article

The Health Policy Check-Up Segment

Ron Lanton, of True North Political Solutions, interviews Jennifer Mallon, vice president and general counsel of the National Community Pharmacists Association, on the health policy check-up segment.

Ron Lanton, of True North Political Solutions, interviews Jennifer Mallon, vice president and general counsel of the National Community Pharmacists Association, on the health policy check-up segment.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Gang | stock.adobe.com
Related Content
Shingles (Herpes Zoster) Vaccination title topic vaccination | Image Credit: daniiiD | stock.adobe.com
August 22nd 2025

Shingles Vaccine Linked to Reduced Risks of Stroke, Myocardial Infarction, and Herpes Zoster Ophthalmicus

Danielle Valletti, Assistant Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 22nd 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Amish children with adult walking | Image Credit: © MMerellinn - stock.adobe.com
August 22nd 2025

The Farm Effect: What Amish Communities Can Teach Us About Allergy Prevention

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
August 22nd 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Vibrant Green Mitragyna Speciosa Plantation Leaves | Image Credit: Yonus | stock.adobe.com
August 22nd 2025

Natural Alkaloids From Mitragyna speciosa Show Potential as Novel HER2 Inhibitors in Breast Cancer

Danielle Valletti, Assistant Editor
Ambulatory chemotherapy | Image Credit: RFBSIP | stock.adobe.com
August 22nd 2025

Limited Benefit of Adjuvant Chemotherapy in Older Women With HR-Positive, HER2-Negative Breast Cancer

Danielle Valletti, Assistant Editor